Welcome to LookChem.com Sign In|Join Free

CAS

  • or

6947-81-5

Post Buying Request

6947-81-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

6947-81-5 Usage

Description

4-(4-ISOPROPYL-PHENYL)-4-OXO-BUTYRIC ACID, commonly known as ibuprofen, is a non-steroidal anti-inflammatory drug (NSAID) that is widely used for its analgesic, antipyretic, and anti-inflammatory properties. It functions by inhibiting the production of prostaglandins, which are lipid compounds that mediate pain, fever, and inflammation. Ibuprofen is available both over-the-counter and in prescription form, making it accessible for a range of conditions.

Uses

Used in Pharmaceutical Industry:
4-(4-ISOPROPYL-PHENYL)-4-OXO-BUTYRIC ACID is used as an analgesic for the relief of mild to moderate pain associated with conditions such as headaches, muscle aches, menstrual cramps, and dental pain. Its ability to alleviate pain is attributed to its capacity to reduce prostaglandin synthesis, thereby decreasing the sensation of pain.
Used in Antipyretic Applications:
In the pharmaceutical industry, 4-(4-ISOPROPYL-PHENYL)-4-OXO-BUTYRIC ACID is utilized as an antipyretic to reduce fever. It achieves this by normalizing body temperature through the inhibition of prostaglandin production, which plays a role in thermoregulation.
Used in Anti-inflammatory Applications:
4-(4-ISOPROPYL-PHENYL)-4-OXO-BUTYRIC ACID is also used as an anti-inflammatory agent to treat inflammation caused by various conditions such as arthritis, sprains, and strains. By inhibiting the production of prostaglandins, it helps to decrease swelling and redness associated with inflammation.
Used in Over-the-Counter Medications:
4-(4-ISOPROPYL-PHENYL)-4-OXO-BUTYRIC ACID is used as an active ingredient in over-the-counter medications for the self-treatment of minor aches, pains, and fevers. Its widespread availability allows individuals to manage common discomforts without a prescription.
Used in Prescription Strength Formulations:
For more severe or chronic conditions, 4-(4-ISOPROPYL-PHENYL)-4-OXO-BUTYRIC ACID is used in prescription strength formulations, providing a higher dosage to address more intense pain and inflammation under medical supervision.

Check Digit Verification of cas no

The CAS Registry Mumber 6947-81-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,9,4 and 7 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 6947-81:
(6*6)+(5*9)+(4*4)+(3*7)+(2*8)+(1*1)=135
135 % 10 = 5
So 6947-81-5 is a valid CAS Registry Number.
InChI:InChI=1/C13H16O3/c1-9(2)10-3-5-11(6-4-10)12(14)7-8-13(15)16/h3-6,9H,7-8H2,1-2H3,(H,15,16)

6947-81-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-oxo-4-(4-propan-2-ylphenyl)butanoic acid

1.2 Other means of identification

Product number -
Other names 4-Oxo-4-p-cumenyl-buttersaeure

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:6947-81-5 SDS

6947-81-5Relevant articles and documents

Organoselenium-catalyzed synthesis of oxygen- and nitrogen-containing heterocycles

Guo, Ruizhi,Huang, Jiachen,Huang, Haiyan,Zhao, Xiaodan

supporting information, p. 504 - 507 (2016/02/18)

A new and efficient approach for the synthesis of oxygen and nitrogen heterocycles by organoselenium catalysis has been developed. The exo-cyclization proceeded smoothly under mild conditions with good functional group tolerance and excellent regioselectivity. Mechanistic studies revealed that 1-fluoropyridinium triflate is key for oxidative cyclization.

NOVEL ANTIBACTERIAL AGENTS FOR THE TREATMENT OF GRAM POSITIVE INFECTIONS

-

, (2010/08/07)

The present invention relates to novel lipopeptide compounds, pharmaceutical compositions of these compounds and methods of using these compounds as antibacterial compounds. The compounds of the invention are particularly useful against a variety of bacte

Transition-Metal-Catalyzed Oxidations, 11.1 Total Synthesis of (±)-Lacinilene C Methyl Ether by β-Naphthol to α-Ketol Oxidation

Krohn, Karsten,Zimmermann, Gregor

, p. 4140 - 4142 (2007/10/03)

-

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 6947-81-5